Dolutegravir Inhibits Proliferation and Motility of BT-20 Tumor Cells Through Inhibition of Human Endogenous Retrovirus Type K

Increasing evidence points to the role of endogenous retroviruses (ERVs) in driving cancer cell proliferation. The purpose of this study was to explore the possibility of repurposing antiretroviral agents to inhibit ERVs as a new approach to cancer treatment. We found that an integrase strand-transf...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiayi, Lin, John, Lin, John R, Farris, Mason, Robbins, Lauren, Andrada, Leo, Grohol, Bryce, Nong, Serrat, Liu, Yingguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345775/
https://www.ncbi.nlm.nih.gov/pubmed/35936147
http://dx.doi.org/10.7759/cureus.26525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345775/
https://www.ncbi.nlm.nih.gov/pubmed/35936147
http://dx.doi.org/10.7759/cureus.26525

Ejemplares similares